News
Consolidated sales amounted to €4,070 million in 2025, up 6.2% like-for-like from €3,980 million in the prior year period. Reported growth stood at +2.3% for the period.
Swipe to discover more
-
bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining high‑precision DNA sequencing, advanced bioinformatics and bioMérieux’s microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve consumer safety. -
Decrease Antibiotic and Steroid Prescribing While Increasing Clinician Confidence: The Strong Case for a Novel Rapid Multiplex PCR in Urgent Care
Combining an antibiotic stewardship program (ASP) with a 15-pathogen viral panel to reduce inappropriate antibiotic prescribing.
-
Rising to the Challenge: Harnessing Diagnostics to Combat Infectious Diseases and AMR
Global health leaders unite to unlock the value of diagnostics in the fight against antimicrobial resistance.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19